168 related articles for article (PubMed ID: 18668144)
1. Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals.
Asokan A; Johnson JS; Li C; Samulski RJ
Gene Ther; 2008 Dec; 15(24):1618-22. PubMed ID: 18668144
[TBL] [Abstract][Full Text] [Related]
2. Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.
Grosse S; Penaud-Budloo M; Herrmann AK; Börner K; Fakhiri J; Laketa V; Krämer C; Wiedtke E; Gunkel M; Ménard L; Ayuso E; Grimm D
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768875
[TBL] [Abstract][Full Text] [Related]
3. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
[TBL] [Abstract][Full Text] [Related]
4. The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes.
Sonntag F; Köther K; Schmidt K; Weghofer M; Raupp C; Nieto K; Kuck A; Gerlach B; Böttcher B; Müller OJ; Lux K; Hörer M; Kleinschmidt JA
J Virol; 2011 Dec; 85(23):12686-97. PubMed ID: 21917944
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.
Earley LF; Powers JM; Adachi K; Baumgart JT; Meyer NL; Xie Q; Chapman MS; Nakai H
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852862
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
7. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid.
Vandenberghe LH; Wang L; Somanathan S; Zhi Y; Figueredo J; Calcedo R; Sanmiguel J; Desai RA; Chen CS; Johnston J; Grant RL; Gao G; Wilson JM
Nat Med; 2006 Aug; 12(8):967-71. PubMed ID: 16845388
[TBL] [Abstract][Full Text] [Related]
8. Single point mutation in adeno-associated viral vectors -DJ capsid leads to improvement for gene delivery in vivo.
Mao Y; Wang X; Yan R; Hu W; Li A; Wang S; Li H
BMC Biotechnol; 2016 Jan; 16():1. PubMed ID: 26729248
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of chimeric recombinant AAV vectors.
Hauck B; Chen L; Xiao W
Mol Ther; 2003 Mar; 7(3):419-25. PubMed ID: 12668138
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
11. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
12. Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2.
Bennett A; Hull J; Jolinon N; Tordo J; Moss K; Binns E; Mietzsch M; Hagemann C; Linden RM; Serio A; Chipman P; Sousa D; Broecker F; Seeberger P; Henckaerts E; McKenna R; Agbandje-McKenna M
J Struct Biol; 2021 Dec; 213(4):107795. PubMed ID: 34509611
[TBL] [Abstract][Full Text] [Related]
13. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
[TBL] [Abstract][Full Text] [Related]
14. Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors.
Du L; Kido M; Lee DV; Rabinowitz JE; Samulski RJ; Jamieson SW; Weitzman MD; Thistlethwaite PA
Mol Ther; 2004 Sep; 10(3):604-8. PubMed ID: 15336660
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.
Yan Z; Zak R; Luxton GW; Ritchie TC; Bantel-Schaal U; Engelhardt JF
J Virol; 2002 Mar; 76(5):2043-53. PubMed ID: 11836382
[TBL] [Abstract][Full Text] [Related]
16. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.
Rabinowitz JE; Rolling F; Li C; Conrath H; Xiao W; Xiao X; Samulski RJ
J Virol; 2002 Jan; 76(2):791-801. PubMed ID: 11752169
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
[TBL] [Abstract][Full Text] [Related]
18. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
[TBL] [Abstract][Full Text] [Related]
19. Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking.
Lux K; Goerlitz N; Schlemminger S; Perabo L; Goldnau D; Endell J; Leike K; Kofler DM; Finke S; Hallek M; Büning H
J Virol; 2005 Sep; 79(18):11776-87. PubMed ID: 16140755
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.
Warrington KH; Gorbatyuk OS; Harrison JK; Opie SR; Zolotukhin S; Muzyczka N
J Virol; 2004 Jun; 78(12):6595-609. PubMed ID: 15163751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]